As detailed in our prior post, the U.S. District Court for the Southern District of Florida recently granted summary judgment against more than 2,450 plaintiffs with cases pending in the Zantac MDL.
Several recent decisions have shed light on the courts' willingness to dismiss a product liability action where the plaintiff lacks sufficiently reliable evidence of general causation.